With the alarming burden of antibiotic resistance, antimicrobial peptides (AMPs) seem to be
novel antimicrobial alternatives for infection treatment due to their rapid broad-spectrum …

Developing novel antimicrobial agents is a top priority in fighting against bacterial
resistance. Thus, a series of new monomer and dimer peptides were designed and …

Abstract Objectives Though antimicrobial peptides (AMPs) show great potential as novel
antibiotics, therapeutic applications are hindered by their low stability, toxicity and high …

Antimicrobial peptides (AMPs) are an essential part of innate immunity. These compounds
have been considered as potential therapeutics because of their broad-spectrum activities …

Antimicrobial peptides (AMPs) have been considered as potential therapeutic sources of
future antibiotics because of their broad-spectrum activities and different mechanisms of …

The emergence of drug resistant bacterium threatens the global public healthcare systems.
The urgent need to obtain new antimicrobials has driven antimicrobial peptides (AMPs) …

Antimicrobial agents have eradicated many infectious diseases and significantly improved
our living environment. However, abuse of antimicrobial agents has accelerated the …

Facing the continuously urgent demands for novel antimicrobial agents since the growing
emergence of bacterial resistance, a series of new ultra-short lipopeptides, composed of …

Antimicrobial peptides (AMPs) show great promise for clinical applications, but the utility of
naturally occurring AMPs is often limited by their stability. Here, we used a rational design …

Antimicrobial peptides (AMPs) have been isolated and characterized from tissues and
organisms representing virtually every kingdom and phylum. Their amino acid composition …